High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)

Riddler, S. A., Moodie, Z., Clark, J., Yen, C., Allen, M., Furch, B. D., Lu, H., Grant, S., Mondal, K., Anderson, M., Maenza, J., Lemos, M. P., Woodward Davis, A. S., Walsh, S. R., Sobieszczyk, M. E., Frank, I., Goepfert, P., Stephenson, K. E., Baden, L. R., … Corey, L. (2025). High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302). Annals of Internal Medicine. https://doi.org/10.7326/annals-24-02701
Authors:
Sharon A Riddler
Zoe Moodie
Jesse Clark
Catherine Yen
Mary Allen
Briana D Furch
Huiyin Lu
Shannon Grant
Kajari Mondal
Maija Anderson
Janine Maenza
Maria P Lemos
Amanda S Woodward Davis
Stephen R Walsh
Magdalena E Sobieszczyk
Ian Frank
Paul Goepfert
Kathryn E Stephenson
Lindsey R Baden
Hong-Van Tieu
Michael C Keefer
M Juliana McElrath
James G Kublin
Lawrence Corey
Affiliated Authors:
Magdalena E Sobieszczyk
Hong-Van Tieu
Publication Type:
Article
Unique ID:
10.7326/annals-24-02701
PMID:
Publication Date:
Data Source:
PubMed

Record Created: